Skip to main content
ConductScienceScienceDex

Qing Zhang

NIH Rank #5137
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8950940Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pathology

NIH Funding · FY2025

Linked Award Amount
$2.3M
Full award amounts, FY2025
Award Records
5
Records listing this PI
Award-Linked Rank
#5,137
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Qing Zhang. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Qing Zhang as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA294636-02R01
    New Von Hippel Lindau (VHL) tumor suppressor signaling in renal cancer
    UT Southwestern Medical Center
    $530.3K
    award amount
  • 1R01CA294133-01A1R01
    Genome-wide CRISPR screening identifies critical regulators controlling ccRCC lung metastasis
    UT Southwestern Medical Center
    $521.6K
    award amount
  • 5R01CA284591-03R01
    Identification of DCLK2-TBK1 signaling axis as a potential therapeutic target in kidney cancer
    UT Southwestern Medical Center
    $469.8K
    award amount
  • 5R01CA274924-03R01
    A New Histone H3 Modification Regulates Epigenetic Programming and Gene Expression in Breast Cancer
    UT Southwestern Medical Center
    $427.7K
    award amount
  • 5R01CA256833-05R01
    BBOX1 is a Novel Oncogenic Driver in Triple Negative Breast Cancer
    UT Southwestern Medical Center
    $395.1K
    award amount

Award organization

Organizations that administered FY2025 awards listing Qing Zhang as a PI.

FY2025 award administered by UT Southwestern Medical Center (TX).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    UT Southwestern Medical Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6620
  5. 2025
    $2M Cumulative Funding
  6. 2025
    R01 Grant Holder
  7. 2026
    $5M Cumulative Funding
  8. 2026
    Entered Top 25% Nationally
    Ranked #2042

Explore further

Find collaborators for Qing Zhang

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →